Cargando…

Cholangiocarcinoma: three different entities based on location

Detalles Bibliográficos
Autores principales:	Aquina, Christopher T., Pawlik, Timothy M., Ejaz, Aslam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7333109/ https://www.ncbi.nlm.nih.gov/pubmed/32647663 http://dx.doi.org/10.21037/atm.2020.03.167

Ejemplares similares

National Trends in the Use of Neoadjuvant Therapy Before Cancer Surgery in the US From 2004 to 2016
por: Aquina, Christopher T., et al.
Publicado: (2021)

Neoadjuvant treatment strategies for intrahepatic cholangiocarcinoma
por: Akateh, Clifford, et al.
Publicado: (2020)

Liver-Directed Treatment Options Following Liver Tumor Recurrence: A Review of the Literature
por: Aquina, Christopher T., et al.
Publicado: (2022)

Disparities in Care Access to Liver-Directed Therapy Among Medicare Beneficiaries with Colorectal Cancer Liver Metastasis
por: Aquina, Christopher T., et al.
Publicado: (2022)

Textbook oncologic outcomes and regionalization among patients undergoing hepatic resection for intrahepatic cholangiocarcinoma
por: Munir, Muhammad M., et al.
Publicado: (2022)

Disparities in access to care among patients with appendiceal or colorectal cancer and peritoneal metastases: A medicare insurance-based study in the United States
por: Aquina, Christopher T., et al.
Publicado: (2022)

Sarcomatoid Cholangiocarcinoma of the Common Bile Duct: An Unusual Entity
por: Moreira Marques, Tatiana, et al.
Publicado: (2023)

Staging and Prognostic Models for Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
por: Burkhart, Richard A., et al.
Publicado: (2017)

Current Perspectives on the Surgical Management of Perihilar Cholangiocarcinoma
por: Hewitt, D. Brock, et al.
Publicado: (2022)

Challenges and Opportunities for Treating Intrahepatic Cholangiocarcinoma
por: Serifis, Nikolaos, et al.
Publicado: (2021)

Surgical Treatment of Intrahepatic Cholangiocarcinoma: Current and Emerging Principles
por: Beal, Eliza W., et al.
Publicado: (2020)

Hot topics in cholangiocarcinoma
por: Brandi, Giovanni
Publicado: (2019)

Location, Location, Location . . . It Is Important in Pancreatitis, Too
por: Liddle, Rodger A.
Publicado: (2016)

Intrahepatic Cholangiocarcinoma: A Summative Review of Biomarkers and Targeted Therapies
por: Acher, Alexandra W., et al.
Publicado: (2021)

Cavitary anomalies of the optic disc: Different entities or part of a single spectrum of disease?
por: Ganesh, Anuradha
Publicado: (2014)

From New Endocrine Entities Requiring New Approaches to New Approaches Leading to New Endocrine Entities
por: Carsote, Mara, et al.
Publicado: (2023)

Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management
por: Lafaro, Kelly J., et al.
Publicado: (2015)

Tuberculous sarcoidosis: Is it a separate entity?
por: Agarwal, Ritesh, et al.
Publicado: (2009)

Interstitial Lung Abnormalities: An Evolving Entity
por: Tomassetti, Sara, et al.
Publicado: (2022)

Current Landscape of Immune Checkpoint Inhibitor Therapy for Hepatocellular Carcinoma
por: Ruff, Samantha M., et al.
Publicado: (2023)

Novel Targeted Therapies for Advanced Cholangiocarcinoma
por: Rizzo, Alessandro, et al.
Publicado: (2021)

Perihilar-cholangiocarcinoma: what really matters?
por: Di Benedetto, Fabrizio, et al.
Publicado: (2022)

Changing Perspectives in the Assessment of Resectability of Hilar Cholangiocarcinoma
por: van Gulik, Thomas M., et al.
Publicado: (2007)

‘Pleomorphic adenoma of the tongue: A common entity at the uncommon location’
por: Chhabra, Sonia, et al.
Publicado: (2018)

Rhabdomyosarcoma and pleomorphic sarcoma in the same location: Recurrence or new entity?
por: Steiner, Daniel, et al.
Publicado: (2021)

Are the Immunohistochemistry-Based Biomarkers Helpful for Predicting Prognosis in Patients with Surgically Resected Cholangiocarcinoma?
por: Kim, Dong Uk
Publicado: (2023)

DNA repair: Location, location, location
por: van Sluis, Marjolein, et al.
Publicado: (2015)

Extracellular Vesicles as a New Therapeutic Entity
por: Yi, Yong Weon
Publicado: (2023)

Intrinsic and environmental factors in intrahepatic cholangiocarcinoma development
por: Yuan, Detian, et al.
Publicado: (2017)

Unveiling resistance mechanisms to EGFR inhibitors in cholangiocarcinoma
por: Vaquero, Javier, et al.
Publicado: (2018)

Pushing the limits for the surgical treatment of intrahepatic cholangiocarcinoma
por: Choi, Woo Jin, et al.
Publicado: (2023)

Surgical Management of Intrahepatic Cholangiocarcinoma: Quo Vadis
por: Moris, Dimitrios
Publicado: (2023)

Targeted therapies in cholangiocarcinoma: light at the end of the tunnel?
por: Amygdalos, Iakovos, et al.
Publicado: (2023)

Location, Location, Location: Usual Source of Care, Kidney Disease Outcomes, and the Social Determinants of Health
por: Quinn, Robert R., et al.
Publicado: (2022)

More accurate reporting of surgical techniques would be SUPER
por: Ruff, Samantha M., et al.
Publicado: (2023)

Different entities of liver failure need clear definitions
por: Christian Pospiech, Josef, et al.
Publicado: (2021)

Telemedicine: Patient-Provider Clinical Engagement During the COVID-19 Pandemic and Beyond
por: Contreras, Carlo M., et al.
Publicado: (2020)

Villous adenoma of the renal pelvis: a common entity at an uncommon location
por: Bharti, Sushma, et al.
Publicado: (2021)

Ancient Schwannoma: Case Report of an Unusual Entity in an Unusual Oral Location
por: Alotaiby, Faraj
Publicado: (2022)

Location for Practice
Publicado: (1869)

Cannot write session to /tmp/vufind_sessions/sess_ivnmqojn9g31hd06a1gqchb2ri